Blackstone, Carlyle and KKR Offer $11.1B For Life Tech.

Apr 12 2013 | 10:13am ET

Three private equity firms have bid $11.1 billion for genetic testing equipment maker Life Technologies, expected to be among the biggest buyouts of the year.

The Blackstone Group, the Carlyle Group and Kohlberg Kravis Roberts, along with Singapore state investment company Temasek Holdings, offered $65 per share for the company. But that opening bid is thought to fall short of the between $65 and $75 per share offered by Thermo Fisher Scientific.

Life Technologies is reviewing the bids and is expected to open negotiations with both bidding groups. A deal could be completed within a few days, The Wall Street Journal reports.


In Depth

Q&A: TCA Fund Management's Bob Press on Small-Cap Private Equity

Aug 25 2016 | 8:55pm ET

The emergence of private credit as a replacement for traditional bank financing...

Lifestyle

Kiawah: Island Reversal

Aug 24 2016 | 9:59pm ET

Looking for real estate investments but the typical real estate fare isn’t cutting...

Guest Contributor

Old Hill Partners: Embrace Illiquidity

Aug 9 2016 | 2:39pm ET

The age-old financial concept that higher yields are the result of higher risk and...